These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34484331)

  • 1. Prognostic Analysis of Lung Adenocarcinoma Based on DNA Methylation Regulatory Factor Clustering.
    Chen Y; Zhong C; Bao S; Fang Z; Tang H
    J Oncol; 2021; 2021():1557968. PubMed ID: 34484331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.
    Lu F; Gao J; Hou Y; Cao K; Xia Y; Chen Z; Yu H; Chang L; Li W
    Front Oncol; 2022; 12():876360. PubMed ID: 35785179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
    Zhou T; Yang P; Tang S; Zhu Z; Li X; Yang Z; Wu R; Tian X; Li L
    J Oncol; 2021; 2021():5512325. PubMed ID: 34367284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
    Li H; Tong L; Tao H; Liu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.
    Zheng Y; Tian H; Zhou Z; Xiao C; Liu H; Liu Y; Wang L; Fan T; Zheng B; Tan F; Xue Q; Gao G; Li C; He J
    Front Cell Dev Biol; 2021; 9():651406. PubMed ID: 33816503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
    Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
    BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
    Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
    Front Oncol; 2021; 11():633420. PubMed ID: 33747955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and Prognosis Analysis of N
    Ma Y; Zhang H
    Front Genet; 2021; 12():746666. PubMed ID: 34956315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expression and prognosis effect of methylation-regulated SLIT3 and SPARCL1 genes in smoking-related lung adenocarcinoma].
    Wang J; Yu XF; Ouyang N; Zhao SY; Guan XF; Yao HP; Chen R; Chen T; Li JX
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1553-1557. PubMed ID: 31154721
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
    Li C; Long Q; Zhang D; Li J; Zhang X
    BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies.
    Xue L; Bi G; Zhan C; Zhang Y; Yuan Y; Fan H
    Front Oncol; 2020; 10():835. PubMed ID: 32537435
    [No Abstract]   [Full Text] [Related]  

  • 20. A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma.
    Ouyang W; Jiang Y; Bu S; Tang T; Huang L; Chen M; Tan Y; Ou Q; Mao L; Mai Y; Yao H; Yu Y; Lin X
    Front Cell Dev Biol; 2021; 9():758777. PubMed ID: 35141229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.